Literature DB >> 11369058

Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry.

K Harada1, T Nishizaki, H Kubota, K Harada1, M Suzuki, K Sasaki.   

Abstract

We investigated chromosomal alterations using comparative genomic hybridization (CGH), and DNA ploidy patterns using laser scanning cytometry (LSC) in 8 primary central nervous system lymphomas (PCNSLs). The average number of chromosomal alterations detected by CGH was 6.9 (gain: 4.1, deletion: 2.8). Frequent alterations were gains of chromosomes 12, 18q, and X, and deletion of 6q, which were similar to those seen in non-CNS diffuse large B-cell lymphoma. DNA aneuploidy was detected by LSC in 4 of the 8 cases. The DNA aneuploid lymphomas had more chromosomal alterations than the DNA diploid ones (9.3 vs. 4.5, P <.05). The former had higher MIB-1 indices than the latter. The present investigation indicates that although most of the PCNSL are histologically uniform, they are divided cytogenetically into DNA aneuploid and diploid tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369058     DOI: 10.1016/s0165-4608(00)00377-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

1.  Laser scanning cytometry: principles and applications.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2006

Review 2.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

Review 4.  Laser scanning cytometry: principles and applications-an update.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Introduction of novel agents in the treatment of primary CNS lymphoma.

Authors:  Christian Grommes; Lakshmi Nayak; Han W Tun; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

Review 6.  The Challenge of Primary Central Nervous System Lymphoma.

Authors:  Julia Carnevale; James L Rubenstein
Journal:  Hematol Oncol Clin North Am       Date:  2016-12       Impact factor: 3.722

Review 7.  Insights into the biology of primary central nervous system lymphoma.

Authors:  Maciej M Mrugala; James L Rubenstein; Maurilio Ponzoni; Tracy T Batchelor
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

8.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

Review 9.  Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.

Authors:  M Ponzoni; S Issa; T T Batchelor; J L Rubenstein
Journal:  Ann Oncol       Date:  2013-11-20       Impact factor: 32.976

10.  Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.

Authors:  Francois M Cady; Brian Patrick O'Neill; Mark E Law; Paul A Decker; David M Kurtz; Caterina Giannini; Alyx B Porter; Paul J Kurtin; Patrick B Johnston; Ahmet Dogan; Ellen D Remstein
Journal:  J Clin Oncol       Date:  2008-07-21       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.